DE185800C - - Google Patents
Info
- Publication number
- DE185800C DE185800C DE1906185800D DE185800DA DE185800C DE 185800 C DE185800 C DE 185800C DE 1906185800 D DE1906185800 D DE 1906185800D DE 185800D A DE185800D A DE 185800DA DE 185800 C DE185800 C DE 185800C
- Authority
- DE
- Germany
- Prior art keywords
- acid
- methylenecitric
- benzene
- methylenecitrylsalicylic
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 18
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 16
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 8
- 229960004889 salicylic acid Drugs 0.000 claims description 8
- HGXYMHQZIAWNKI-UHFFFAOYSA-L disodium;2-[4-(carboxylatomethyl)-5-oxo-1,3-dioxolan-4-yl]acetate Chemical compound [Na+].[Na+].[O-]C(=O)CC1(CC([O-])=O)OCOC1=O HGXYMHQZIAWNKI-UHFFFAOYSA-L 0.000 claims description 7
- MZRMRMTUUHHONC-UHFFFAOYSA-N 2-[2-[4-[2-(2-carboxyphenoxy)-2-oxoethyl]-5-oxo-1,3-dioxolan-4-yl]acetyl]oxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OC(=O)CC1(CC(=O)OC=2C(=CC=CC=2)C(O)=O)C(=O)OCO1 MZRMRMTUUHHONC-UHFFFAOYSA-N 0.000 claims description 5
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- 230000005283 ground state Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- QJPSALCLPXHRIP-UHFFFAOYSA-L dipotassium;2-carboxyphenolate Chemical compound [K+].[K+].OC(=O)C1=CC=CC=C1[O-].OC(=O)C1=CC=CC=C1[O-] QJPSALCLPXHRIP-UHFFFAOYSA-L 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- FRMWBRPWYBNAFB-UHFFFAOYSA-M potassium salicylate Chemical compound [K+].OC1=CC=CC=C1C([O-])=O FRMWBRPWYBNAFB-UHFFFAOYSA-M 0.000 description 1
- 229960003629 potassium salicylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT32639D AT32639B (de) | 1906-03-22 | 1906-10-31 | Verfahren zur Darstellung von Methylenzitrylsalizylsäure. |
Publications (1)
Publication Number | Publication Date |
---|---|
DE185800C true DE185800C (en, 2012) |
Family
ID=449609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1906185800D Expired - Lifetime DE185800C (en, 2012) | 1906-03-22 | 1906-03-22 |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE185800C (en, 2012) |
-
1906
- 1906-03-22 DE DE1906185800D patent/DE185800C/de not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE185800C (en, 2012) | ||
AT32639B (de) | Verfahren zur Darstellung von Methylenzitrylsalizylsäure. | |
AT117475B (de) | Verfahren zur Darstellung von Substitutionsprodukten des ß-Jodpyridins. | |
DE960197C (de) | Verfahren zur Herstellung von in 4-Stellung durch eine Sulfonsaeuredialkylamidgruppe substituierten 2-Chlorbenzoesaeuren | |
DE679711C (de) | Verfahren zur Herstellung von AEthersaeuren | |
DE193114C (en, 2012) | ||
DE836650C (de) | Verfahren zur Herstellung reiner Folinsaeure | |
DE538981C (de) | Verfahren zur Darstellung von Tetrazolen | |
DE283538C (en, 2012) | ||
DE708149C (de) | Verfahren zur Herstellung von 1íñ3-, 1íñ4- und 1íñ3íñ5-Benzolcarbonsaeurechloriden | |
DE579147C (de) | Verfahren zur Herstellung von leicht loeslichen Salzen der Gallensaeuren | |
DE752371C (de) | Verfahren zur Herstellung von Enolaethern von 3-Ketosteroiden | |
DE730789C (de) | Verfahren zur Darstellung von 1-Oxyaryloxy-3-alkoxy-2-propanolen bzw. -2-propanonen | |
DE409345C (de) | Verfahren zur Darstellung von Oxazolinen | |
DE507418C (de) | Verfahren zur Darstellung von Derivaten der Phenoxyphenole | |
DE710718C (de) | Verfahren zur Herstellung von Kondensationsprodukten aus Ketopolyhydronaphthalinen und reaktionsfaehigen organischen Verbindungen | |
DE634285C (de) | Verfahren zur Darstellung von Abkoemmlingen des 2, 4-Dioxotetrahydropyridins | |
DE706938C (de) | Verfahren zur Herstellung von polyjodierten Abkoemmlingen von Homologen von Oxyphenylphenylessigsaeuren | |
DE468808C (de) | Verfahren zur Herstellung von komplexen Silbercyanidpraeparaten | |
DE177054C (en, 2012) | ||
DE737023C (de) | Verfahren zur Darstellung von AEtiocholylglyoxalen | |
DE171790C (en, 2012) | ||
DE516845C (de) | Verfahren zur Darstellung von Salzen saurer Schwefelsaeureester von Nitroanthrahydrochinonen | |
DE633981C (de) | Verfahren zur Herstellung wohldefinierter kristalliner Nitrate des Phenylquecksilberhydroxyds | |
DE84142C (en, 2012) |